Theories of otitis media pathogenesis, with a focus on Indigenous children

Medical Journal of Australia

Volumn 191, Issue SUPPL. 9, 2009, Pages

  Wiertsema, Selma P ^a   Leach, Amanda J ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ARTICLE; AUSTRALIA; CHILD; ETHNOLOGY; HUMAN; IMMUNOLOGY; INFANT; INNATE IMMUNITY; MICROBIOLOGY; NASOPHARYNX; OTITIS MEDIA; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR;

AUSTRALIA; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNITY, INNATE; INFANT; NASOPHARYNX; OCEANIC ANCESTRY GROUP; OTITIS MEDIA; PREVALENCE; RISK FACTORS;

EID: 77950366989     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02927.x     Document Type: Article

References (56)

1. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367: 740-748.
2. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989; 160: 83-94.
3. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403-409.
4. Leach AJ, Morris PS, Mathews JD. Compared with placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial. BMC Pediatr 2008; 8: 23.
5. Rothstein J, Heazlewood R, Fraser M. Health of Aboriginal and Torres Strait Islander children in remote Far North Queensland: findings of the Paediatric Outreach Service. Med J Aust 2007; 186: 519-521.
6. Morris PS, Leach AJ, Silberberg P, et al. Otitis media in young Aboriginal children from remote communities in northern and central Australia: a cross-sectional survey. BMC Pediatr 2005; 5: 27.
7. Smith-Vaughan H, Byun R, Nadkarni M, et al. Measuring nasal bacterial load and its association with otitis media. BMC Ear Nose Throat Disord 2006; 6: 10.
8. Ashhurst-Smith C, Hall ST, Walker P, et al. Isolation of Alloiococcus otitidis from Indigenous and non-Indigenous Australian children with chronic otitis media with effusion. FEMS Immunol Med Microbiol 2007; 51: 163-170.
9. Nokso-Koivisto J, Raty R, Blomqvist S, et al. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol 2004; 72: 241-248.
10. Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982; 306: 1377-1383.
11. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359: 1555-1564.
12. Jacoby P, Watson K, Bowman J, et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine 2006; 25: 2458-2464.
13. Palmu AA, Herva E, Savolainen H, et al. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 2004; 38: 234-242.
14. Leibovitz E, Serebro M, Givon-Lavi N. Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media. Pediatr Infect Dis J 2009; 28: 381-384.
15. Leach A. Microbiology of otitis media with perforation in Indigenous children, streptococci - new insights into an old enemy. In: Kadaba E, Sriprakash S, editors. Proceedings of the XVIth Lancefield International Symposium on Streptococci and Streptococcal Diseases; 2006 Sep 25-29; Cairns, Qld: 89-92.
16. Rosenfeld R, Bluestone C, editors. Evidence based otitis media. 2nd ed. London: BC Decker, 2003.
17. Leach A, Wood Y, Gadil E, et al. Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian Aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial. Pediatr Infect Dis J 2008; 27: 692-698.
18. Altuntas A, Aslan A, Eren N, et al. Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Eur Arch Otorhinolaryngol 1996; 253: 364-366.
19. Nyembue DT, Tshiswaka JM, Sabue MJ, Muyunga CK. Bacteriology of chronic suppurative otitis media in Congolese children. Acta Otorhinolaryngol Belg 2003; 57: 205-208.
20. Sharma S, Rehan HS, Goyal A, et al. Bacteriological profile in chronic suppurative otitis media in Eastern Nepal. Trop Doct 2004; 34: 102-104.
21. Aslam MA, Ahmed Z, Azim R. Microbiology and drug sensitivity patterns of chronic suppurative otitis media. J Coll Physicians Surg Pak 2004; 14: 459-461.
22. Leach AJ, Boswell JB, Asche V, et al. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants. Pediatr Infect Dis J 1994; 13: 983-989.
23. Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15.
24. Leach AJ, Morris PS. Perspectives on infective ear disease in Indigenous Australian children. J Paediatr Child Health 2001; 37: 529-530.
25. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ. Bronchiectasis in Indigenous children in remote Australian communities. Med J Aust 2002; 177: 200-204.
26. Smith-Vaughan H, Byun R, Halpin S, et al. Interventions for prevention of otitis media may be most effective if implemented in the first weeks of life. Int J Pediatr Otorhinolaryngol 2008; 72: 57-61.
27. Stubbs E, Hare K, Wilson C, et al. Streptococcus pneumoniae and noncapsular Haemophilus influenzae nasal carriage and hand contamination in children: a comparison of two populations at risk of otitis media. Pediatr Infect Dis J 2005; 24: 423-428.
28. Silva DT, Lehmann D, Tennant MT, et al. Effect of swimming pools on antibiotic use and clinic attendance for infections in two Aboriginal communities in Western Australia. Med J Aust 2008; 188: 594-598.
29. Abdullahi O, Nyiro J, Lewa P, et al. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyn geal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J 2008; 27: 59-64.
30. Gratten M, Gratten H, Poli A, et al. Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers. Biol Neonate 1986; 50: 114-120.
31. Vives M, Garcia ME, Saenz P, et al. Nasopharyngeal colonization in Costa Rican children during the first year of life. Pediatr Infect Dis J 1997; 16: 852-858.
32. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J Infect Dis 1997; 175: 1440-1445.
33. Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142: 923-933.
34. Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 2008; 46: 807-814.
35. Faden H, Waz MJ, Bernstein JM, et al. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol 1991; 100: 612-615.
36. Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: a twin and triplet study. JAMA 1999; 282: 2125-2130.
37. Curns AT, Holman RC, Shay DK, et al. Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. Pediatrics 2002; 109: E41.
38. Leach AJ. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol 1999; 49 Suppl 1: S173-S178.
39. García-Rodríguez JA, Fresnadillo Martínez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother 2002; 50 Suppl S2: 59-73.
40. Lee HY, Andalibi A, Webster P, et al. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis 2004; 4: 12.
41. Song JJ, Cho JG, Woo JS, et al. Differential expression of toll-like receptors 2 and 4 in rat middle ear. Int J Pediatr Otorhinolaryngol 2009; 73: 821-824.
42. Hernandez M, Leichtle A, Pak K, et al. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J Infect Dis 2008; 198: 1862-1869.
43. Hirano T, Kodama S, Fujita K, et al. Role of toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media. FEMS Immunol Med Microbiol 2007; 49: 75-83.
44. Wiertsema SP, Herpers BL, Veenhoven RH, et al. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol 2006; 117: 1344-1350.
45. Homoe P, Madsen HO, Sandvej K, et al. Lack of association between mannose-binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand J Infect Dis 1999; 31: 363-366.
46. Straetemans M, Wiertsema SP, Sanders EA, et al. Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and Fc receptor polymorphisms for IgG. J Clin Immunol 2005; 25: 78-86.
47. Wiertsema SP, Khoo S-K, Baynam G, et al. Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin Vaccine Immunol 2006; 13: 892-897.
48. Lodrup Carlsen KC, Granum B. Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr Allergy Asthma Rep 2007; 7: 436-443.
49. Balmer P, Borrow R, Findlow J, et al. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease before the introduction of the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol 2007; 14: 1442-1450.
50. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr 2001; 160: 407-413.
51. Zhang Q, Bernatoniene J, Bagrade L, et al. Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur J Immunol 2006; 36: 46-57.
52. Simell B, Kilpi T, Kayhty H. Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children. Clin Exp Immunol 2006; 143: 543-549.
53. McMahon M, Murphy TF, Kyd J, Thanavala Y. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 2005; 23: 3590-3596.
54. Malley R, Srivastava A, Lipsitch M, et al. Antibody-independent, interleukin- 17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 2006; 74: 2187-2195.
55. Morris PS, Gadil JR, McCallum GB, et al. Single-dose azithromycin versus 7 days amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial. Med J Aust. In press.
56. Moran DJ, Waterford JE, Hollows F, Jones DL. Ear disease in rural Australia. Med J Aust 1979; 2: 210-212.